Omron (OTCMKTS:OMRNY) Issues FY 2026 Earnings Guidance

Omron (OTCMKTS:OMRNY) issued an update on its FY 2026 earnings guidance on Wednesday morning. The company provided EPS guidance of 0.890-0.890 for the period, compared to the consensus EPS estimate of 1.220. The company issued revenue guidance of $5.2 billion-$5.2 billion, compared to the consensus revenue estimate of 0.000.

Omron Stock Down 2.1%

Shares of OTCMKTS OMRNY opened at $38.87 on Wednesday. The company has a debt-to-equity ratio of 0.13, a current ratio of 2.11 and a quick ratio of 1.37. The stock has a market capitalization of $7.64 billion, a PE ratio of 49.20, a P/E/G ratio of 0.46 and a beta of 1.16. Omron has a one year low of $23.23 and a one year high of $40.76. The business’s fifty day moving average price is $31.08 and its 200-day moving average price is $28.43.

Wall Street Analysts Forecast Growth

Separately, Zacks Research raised shares of Omron from a “strong sell” rating to a “hold” rating in a research note on Monday, January 19th. One research analyst has rated the stock with a Hold rating, According to MarketBeat.com, Omron presently has a consensus rating of “Hold”.

About Omron

Omron Corporation (OTCMKTS: OMRNY) is a global leader in automation, sensing, and control technologies. The company designs, manufactures, and sells a wide range of products and solutions for industrial, healthcare and social systems applications. Its core business segments include industrial automation—featuring programmable logic controllers, sensors, relays, servo motors and temperature controllers—and healthcare products such as blood pressure monitors, digital thermometers and nebulizers.

Founded in 1933 by Kazuma Tateishi in Kyoto, Japan, Omron began with the development of the first Japanese automatic timer.